Patents by Inventor Hiroaki Udagawa

Hiroaki Udagawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140287475
    Abstract: The present invention relates to methods for reducing or eliminating the expression of a target gene in a filamentous fungal strain, comprising: (a) inserting into the genome of the filamentous fungal strain a double-stranded transcribable nucleic acid construct comprising a first nucleotide sequence comprising a promoter operably linked to a homologous coding region of the target gene and a second nucleotide sequence comprising the homologous coding region, or a portion thereof, of the target gene, wherein the first and second nucleotide sequences are complementary to each other and the second nucleotide sequence is in reverse orientation relative to the first nucleotide sequence; and (b) inducing production of an interfering RNA encoded by the double-stranded transcribable nucleic acid construct by cultivating the filamentous fungal strain under conditions conducive for production of the interfering RNA; wherein the interfering RNA interacts with RNA transcripts of the target gene to reduce or eliminate exp
    Type: Application
    Filed: April 17, 2014
    Publication date: September 25, 2014
    Applicants: Novozymes A/S, Novozymes, Inc.
    Inventors: Howard Brody, Suchindra Maiyuran, Hiroaki Udagawa
  • Patent number: 8841091
    Abstract: The present invention relates to polypeptides comprising a carbohydrate-binding module amino acid sequence and an alpha-amylase amino acid sequence as well as to the application of such polypeptides.
    Type: Grant
    Filed: November 2, 2012
    Date of Patent: September 23, 2014
    Assignees: Novozymes Als, Novozymec North America Inc.
    Inventors: Shiro Fukuyama, Tomoko Matsui, Chee Leong Soong, Eric Allain, Anders Vikso Nielsen, Hiroaki Udagawa, Ye Liu, Junxin Duan, Wenping Wu, Lene Nonboe Andersen
  • Patent number: 8802412
    Abstract: The present invention relates to isolated polynucleotides having promoter activity the use of the isolated polynucleotides for the production of a polypeptide. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing a desired polypeptide using the polypeptide having promoter activity.
    Type: Grant
    Filed: June 23, 2011
    Date of Patent: August 12, 2014
    Assignee: Novozymes A/S
    Inventors: Hiroshi Teramoto, Hiroaki Udagawa, Rikako Taira
  • Patent number: 8735563
    Abstract: The present invention relates to isolated polynucleotides having promoter activity the juse of the isolated polynucleotides for the procuction of a polypeptide. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing a desired polypeptide using the polypeptide having promoter activity.
    Type: Grant
    Filed: June 23, 2011
    Date of Patent: May 27, 2014
    Assignee: Novozymes A/S
    Inventors: Hiroshi Teramoto, Hiroaki Udagawa
  • Publication number: 20140127753
    Abstract: The present invention relates to polypeptides comprising a carbohydrate-binding module amino acid sequence and an alpha-amylase amino acid sequence as well as to the application of such polypeptides.
    Type: Application
    Filed: November 2, 2012
    Publication date: May 8, 2014
    Inventors: Shiro Fukuyama, Tomoko Matsui, Chee Leong Soong, Eric Allain, Anders Vikso Nielsen, Hiroaki Udagawa, Ye Liu, Junxin Duan, Wenping Wu, Lene Nonboe Andersen
  • Patent number: 8716023
    Abstract: The present invention relates to methods for reducing or eliminating the expression of a target gene in a filamentous fungal strain, comprising: (a) inserting into the genome of the filamentous fungal strain a double-stranded transcribable nucleic acid construct comprising a first nucleotide sequence comprising a promoter operably linked to a homologous coding region of the target gene and a second nucleotide sequence comprising the homologous coding region, or a portion thereof, of the target gene, wherein the first and second nucleotide sequences are complementary to each other and the second nucleotide sequence is in reverse orientation relative to the first nucleotide sequence; and (b) inducing production of an interfering RNA encoded by the double-stranded transcribable nucleic acid construct by cultivating the filamentous fungal strain under conditions conducive for production of the interfering RNA; wherein the interfering RNA interacts with RNA transcripts of the target gene to reduce or eliminate exp
    Type: Grant
    Filed: December 9, 2004
    Date of Patent: May 6, 2014
    Assignees: Novozymes, Inc., Novozymes A/S
    Inventors: Howard Brody, Suchindra Maiyuran, Hiroaki Udagawa
  • Publication number: 20140120625
    Abstract: The invention relates to a method for the simultaneous integration of two or more copies of a polynucleotide of interest into the chromosome of a fungal host cell comprising at least two pairs of recognition sequences of a site-specific recombinase, each pair flanking a resident negative selection marker; transformation of the cell with a construct carrying a gene of interest also flanked by the recognition sequences to ensure double-crossover events after transient expression of the recombinase, followed by selection for excision of all negative selection markers from the cell.
    Type: Application
    Filed: May 23, 2012
    Publication date: May 1, 2014
    Inventor: Hiroaki Udagawa
  • Publication number: 20140113304
    Abstract: The present invention relates to a bi-directional cytosine deaminase-encoding selection marker as well as methods for using said marker.
    Type: Application
    Filed: May 23, 2012
    Publication date: April 24, 2014
    Applicant: Novozymes A/S
    Inventor: Hiroaki Udagawa
  • Patent number: 8633010
    Abstract: The present invention relates to an isolated polypeptide having PepC inhibitory activity as well as to a method for producing a heterologous polypeptide of interest in an Aspergillus host cell comprising: (a) cultivating the Aspergillus host cell comprising a first and a second nucleic acid sequences under conditions conducive for the expression of the polypeptides encoded by the said first and second nucleic acid sequences, and wherein the first nucleic acid sequence encodes a heterologous polypeptide of interest and the second nucleic acid encodes the inhibitor polypeptide of the invention, and wherein the inhibitor polypeptide is expressed from a recombinant nucleic acid construct resulting in an increased level of the inhibitor polypeptide compared to an Aspergillus host cell not comprising the recombinant nucleic acid construct; and (b) recovering the heterologous polypeptide.
    Type: Grant
    Filed: December 2, 2008
    Date of Patent: January 21, 2014
    Assignee: Novozymes A/S
    Inventors: Jan Lehmbeck, Hiroaki Udagawa
  • Patent number: 8512986
    Abstract: The present invention relates to polypeptides comprising a carbohydrate-binding module amino acid sequence and an alpha-amylase amino acid sequence as well as to the application of such polypeptides.
    Type: Grant
    Filed: December 20, 2010
    Date of Patent: August 20, 2013
    Assignees: Novozymes A/S, Novozymes North America, Inc.
    Inventors: Shiro Fukuyama, Tomoko Matsui, Chee Leong Soong, Eric Allain, Anders Vikso Nielsen, Hiroaki Udagawa, Ye Liu, Junxin Duan, Wenping Wu, Lene Nonboe Andersen, Sara Landvik
  • Publication number: 20130095525
    Abstract: The present invention relates to isolated polynucleotides having leader sequence function. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods using the polynucleotides for production of polypeptides.
    Type: Application
    Filed: June 23, 2011
    Publication date: April 18, 2013
    Applicant: NOVOZYMES A/S
    Inventors: Hiroaki Udagawa, Rikako Taira, Shinobu Takagi
  • Publication number: 20130095550
    Abstract: The present invention relates to isolated polynucleotides having promoter activity the use of the isolated polynucleotides for the production of a polypeptide. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing a desired polypeptide using the polypeptide having promoter activity.
    Type: Application
    Filed: June 23, 2011
    Publication date: April 18, 2013
    Applicant: NOVOZYMES A/S
    Inventors: Hiroshi Teramoto, Hiroaki Udagawa, Rikako Taira
  • Publication number: 20130090463
    Abstract: The present invention relates to isolated polynucleotides having promoter activity the juse of the isolated polynucleotides for the procuction of a polypeptide. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing a desired polypeptide using the polypeptide having promoter activity.
    Type: Application
    Filed: June 23, 2011
    Publication date: April 11, 2013
    Applicant: NOVOZYMES A/S
    Inventors: Hiroshi Teramoto, Hiroaki Udagawa
  • Patent number: 8383391
    Abstract: This disclosure relates to mutant cells with deleted or disrupted genes encoding protease(s).
    Type: Grant
    Filed: September 30, 2008
    Date of Patent: February 26, 2013
    Assignee: Novozymes A/S
    Inventors: Hiroaki Udagawa, Christian Isak Jørgensen
  • Publication number: 20120294978
    Abstract: The present invention relates to a hybrid enzyme comprising carbohydrate-binding module amino acid sequence and a fungal alpha-amylase amino acid sequence and to a variant of a fungal wild type enzyme comprising a carbohydrate-binding module and an alpha-amylase catalytic module. The invention also relates to the use of the hybrid enzyme or the variant in starch liquefaction.
    Type: Application
    Filed: July 19, 2012
    Publication date: November 22, 2012
    Applicants: NOVOZYMES NORTH AMERICA, INC., NOVOZYMES A/S
    Inventors: Hiroaki Udagawa, Rikako Taira, Shinobu Takagi, Carsten Hjort, Anders Vikso-Nielson, Eric Allain, Shiro Fukuyama, Tomoko Matsui
  • Patent number: 8263381
    Abstract: The present invention relates to a hybrid enzyme comprising carbohydrate-binding module amino acid sequence and a fungal alpha-amylase amino acid sequence and to a variant of a fungal wild type enzyme comprising a carbohydrate-binding module and an alpha-amylase catalytic module. The invention also relates to the use of the hybrid enzyme or the variant in starch liquefaction.
    Type: Grant
    Filed: August 20, 2010
    Date of Patent: September 11, 2012
    Assignees: Novozyms A/S, Novozymes North America, Inc.
    Inventors: Hiroaki Udagawa, Rikako Taira, Shinobu Takagi, Carsten Hjort, Anders Vikso-Nielsen, Eric Allain, Shiro Fukuyama, Tomoko Matsui
  • Patent number: 8148127
    Abstract: The present invention relates to polypeptides having glucoamylase activity and isolated polynucleotides encoding said polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides. The invention also relates to the composition comprising a glucoamylase of the invention as well as the use such compositions for starch conversion processes, brewing, including processes for producing fermentation products or syrups.
    Type: Grant
    Filed: December 10, 2009
    Date of Patent: April 3, 2012
    Assignees: Novozymes A/S, Novozymes North America, Inc.
    Inventors: Hiroaki Udagawa, Sara Landvik, Michiko Ihara, Jiyin Liu, Chee Leong Soong, Eric Allain, Shiro Fukuyama
  • Publication number: 20110104759
    Abstract: The present invention relates to polypeptides comprising a carbohydrate-binding module amino acid sequence and an alpha-amylase amino acid sequence as well as to the application of such polypeptides.
    Type: Application
    Filed: December 20, 2010
    Publication date: May 5, 2011
    Applicants: Novozymes A/S, Novozymes North America, Inc.
    Inventors: Shiro Fukuyama, Tomoko Matsui, Chee Leong Soong, Eric Allain, Anders Vikso Nielsen, Hiroaki Udagawa, Ye Liu, Junxin Duan, Wenping Wu, Lene Nonboe Andersen
  • Patent number: 7883883
    Abstract: The present invention relates to a hybrid enzyme comprising carbohydrate-binding module amino acid sequence and a fungal alpha-amylase amino acid sequence and to a variant of a fungal wild type enzyme comprising a carbohydrate-binding module and an alpha-amylase catalytic module. The invention also relates to the use of the hybrid enzyme or the variant in starch liquefaction.
    Type: Grant
    Filed: June 25, 2004
    Date of Patent: February 8, 2011
    Assignees: Novozymes A/S, Novozymes North America, Inc.
    Inventors: Hiroaki Udagawa, Rikako Taira, Shinobu Takagi, Carsten Hjort, Anders Vikso-Nielsen, Eric Allain, Shiro Fukuyama, Tomoko Matsui
  • Publication number: 20100323061
    Abstract: The present invention relates to a hybrid enzyme comprising carbohydrate-binding module amino acid sequence and a fungal alpha-amylase amino acid sequence and to a variant of a fungal wild type enzyme comprising a carbohydrate-binding module and an alpha-amylase catalytic module. The invention also relates to the use of the hybrid enzyme or the variant in starch liquefaction.
    Type: Application
    Filed: August 20, 2010
    Publication date: December 23, 2010
    Applicants: Novozymes A/S, Novozymes North America, Inc.
    Inventors: Hiroaki Udagawa, Rikako Taira, Shinobu Takagi, Eric Allain, Carsten Hjort, Anders Vikso-Nielsen, Shiro Fukuyama, Tomoko Matsui